Table 1. Consensus guidelines for managing DME.
Consensus | Supporting data |
Treatment goal | RISE/RIDE (2012)[21] |
MEAD (2014)[22] | |
RESTORE (2011)[20] | |
VIVID/VISTA (2014)[23] | |
DRCR.net Protocol I (2010)[24] | |
DRCR.net Protocol T (2015) [25] | |
DME treatment options | |
Anti-vascular endothelial growth factor | RESTORE (2011)[20] |
Robert & Gabriel (2016)[28] | |
Curry et al (2020)[26] | |
Zabrin et al (2017)[29] | |
DRCR.net Protocol T (2015)[25] | |
Ademan & Garg (2017)[27] | |
Jain et al (2017)[30] | |
Steroid implant | MAED (2014)[21] |
Bucolo et al (2018)[31] | |
Focal/grid laser | EURETINA (2017)[1] |
Ademan & Garg (2017)[27] | |
Pai et al (2010)[32] | |
Pars plana vitrectomy + membrane peeling | Gary et al (2017)[33] |
Special conditions | |
Blood sugar control | Mathew et al (2015)[34] |
Rajalakshmi et al (2016)[35] | |
Cataract surgery | Chhablani et al (2020)[36] |
Treatment in pregnant DME patients | Peracha et al (2015)[37] |
Rosenthal & Johnson (2018)[38] | |
Mathew et al (2015)[34] | |
Yoo et al (2016)[39] | |
Vitrectomized eyes | Chhablani et al (2020)[36] |
Medeiros et al (2014)[40] | |
Stable pre-existing glaucoma | Chhablani et al (2020)[36] |
Lakhani et al (2020)[41] | |
Endophthalmitis | Pai et al (2010)[32] |
McCannel (2011)[42] | |
Kiss et al (2018)[43] | |
Goel (2017)[44] | |
Treatment algorithm for DME | Chhablani et al (2020)[36] |
DME: Diabetic macular edema.